| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.0007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |